Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAngle Share News (AGL)

Share Price Information for Angle (AGL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 14.25
Bid: 14.00
Ask: 14.50
Change: 0.00 (0.00%)
Spread: 0.50 (3.571%)
Open: 14.25
High: 14.25
Low: 14.25
Prev. Close: 14.25
AGL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Small caps round-up: HMV, Corero, ANGLE ...

Thu, 15th Mar 2012 12:06

HMV Group, the struggling entertainment media seller, has confirmed that it is still pondering what to do with its live music business. HMV added that a number of parties have indicated an interest in acquiring the business. There has been press speculation recently about who might be interested in buying HMV's live music arm, which is one of the few parts of the business enjoying growth. Corero Network Security's Distributed Denial of Service (DDoS) Defence System has been named the "Best Security Product and Solution for Large Enterprises" in the Info Security Products Guide, 2012 Global Excellence Awards. The product defends against DDoS attacks which now occur at the application-layer, quickly exhausting local server resources while going undetected by conventional DDoS detection solutions, the firm said. ANGLE, a technology commercialisation company, has confirmed that its Parsortix cell separation device can capture colon cancer cells, creating the possibility of developing an effective, non-invasive screening technique to enable the early diagnosis and monitoring of colo-rectal cancer.Trinity Mirror is launching "happli", a nationwide daily deals business, focused on attracting and retaining loyal, long-term customers for retailers. The launch is supported by a £10m investment over the next two years with the business forecast to deliver net revenues of around £20m by 2014. There are significant opportunities to drive new revenues from this market which was estimated to be valued at around £100m in 2011 and is forecast to rise to over £1bn by 2016. Powerflute Oyj, a packaging and paper group, has reported a 15% rise in revenues from €105.4m to €121.4m during the year ended December 31st. Pre-tax profit almost tripled from €4.8m to €12.4m. Earnings per share rose to 3.5 cents from -13.3 cents. Cash at the end of the period stood at €43.6m compared to €18.7m the same date the previous year. The directors intend to recommend a dividend for 2011 of 1.3 cents per share (2010: 1.0 cents per share) Plethora Solutions has announced the postive outcome of pre-submission meetings held with the Rapporteur and Co-Rapporteur (Spain and the UK respectively) for its PSD502 treatment for premature ejaculation. The company is now on track to file the dossier with the European Medicines Agency in the first half of this year. Plethora said it is "delighted" by the response from the two agencies involved in the review. Surgical Innovations Group, a manufacturer of medical supplies, has received clearance from the US Food and Drug Administration for is reusable PretzelFlex device. This clearance permits the use of PretzelFlex in the US market for organ and tissue retraction.Stilo International, a software and services firm, posted a fall in pre-tax profit from £0.142m to £0.105m for the year ended December 31st. Sales revenue fell from £2.38m to £1.74m, while operating expenses were reduced by 17% to £1.5m (2010: £1.8m). Cash more than doubled at the year end, from £0.49m to £0.93m. NR
More News
5 Jun 2024 16:32

EARNINGS AND TRADING: STV sees advertising upturn; Angle loss narrows

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
5 Jun 2024 10:08

Angle unveils plans to raise more than £10m

(Sharecast News) - Liquid biopsy specialist Angle is to raise more than £10m to support future growth, the UK company announced on Wednesday.

Read more
16 May 2024 20:09

TRADING UPDATES: Bens Creek considers administration; Nexxen inks deal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
16 May 2024 11:46

Angle reports promising results from Parsortix study

(Sharecast News) - Angle, the AIM-listed liquid biopsy company which specialises in circulating tumour cell (CTC) solutions, has announced the results of a clinical study which show that its Parsortix system could be used to predict progression-free survival in patients with ovarian cancer.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 10:52

AIM WINNERS & LOSERS: Fletcher King optimistic; Angle in Astra deal

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
3 May 2024 08:48

LONDON MARKET OPEN: Confident start before US jobs data

(Alliance News) - Stock prices in London opened higher on Friday, on the rising conviction that the afternoon's US jobs report will be softer, cooling some hawkish Federal Reserve interest rate expectations.

Read more
3 May 2024 07:58

Angle strikes supplier deal with AstraZeneca

(Sharecast News) - Liquid biopsy technology firm Angle has struck a supplier deal with pharmaceutical giant AstraZeneca to develop an androgen receptor detection assay to enhance prostate cancer studies.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
24 Apr 2024 17:06

CORRECT: No record close for FTSE 100; mixed trade in US

(Correcting day of the week in the opening sentence.)

Read more
24 Apr 2024 17:00

LONDON MARKET CLOSE: No record close for FTSE 100; mixed trade in US

(Alliance News) - Stock prices in London closed lower on Thursday, with the FTSE 100's recent rally taking a pause for breath, but not after hitting another record high.

Read more
24 Apr 2024 10:32

Angle shares jump on supplier agreement with with AstraZeneca

(Alliance News) - Angle PLC shares rose on Wednesday, after it signed a contract with AstraZeneca PLC.

Read more
24 Apr 2024 10:10

AIM WINNERS & LOSERS: Filtronic jumps as lifts outlook

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
22 Apr 2024 16:52

IN BRIEF: Angle granted patents in US and Europe for Cellkeep slide

Angle PLC - Surrey-based medical diagnostics provider - Says it has been granted a European and US patent for its CellKeep slide. "We are delighted to have secured intellectual property rights for our proprietary CellKeep slide in two major jurisdictions....This is a significant technology advancement for the [circulating tumor cell] liquid biopsy field and another step towards enabling biomarker-guided precision medicine for people with cancer," says Chief Executive Officer Andrew Newland. The CellKeep slide was developed by Angle to reduce cell loss during the transfer of CTCs to the microscope slide and to protect the morphology of the harvested cells.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.